Literature DB >> 23816801

Epigenomic control of the innate immune response.

Joshua D Stender1, Christopher K Glass.   

Abstract

Toll-like receptors (TLRs) play important roles in initiation of innate immune responses and promotion of pathological forms of inflammation. Recent technological advances have enabled the visualization of transcription factor binding and histone modifications in response to TLR signaling at genome-wide levels. Findings emerging from these studies are beginning to provide a picture of how signal-dependent transcription factors regulate the inflammatory response in a cell-specific manner by controlling the recruitment of nucleosome remodeling factors and histone modifying enzymes. Of particular interest, new small molecule inhibitors have been developed that influence inflammatory responses by altering the reading or erasure of histone modifications required for inflammatory gene activation. These findings suggest new approaches for treatment of inflammatory diseases.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23816801      PMCID: PMC5733719          DOI: 10.1016/j.coph.2013.06.002

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  54 in total

1.  Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages.

Authors:  Yury I Miller; Suganya Viriyakosol; Dorothy S Worrall; Agnès Boullier; Susan Butler; Joseph L Witztum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-17       Impact factor: 8.311

2.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

3.  Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages.

Authors:  Serena Ghisletti; Iros Barozzi; Flore Mietton; Sara Polletti; Francesca De Santa; Elisa Venturini; Lorna Gregory; Lorne Lonie; Adeline Chew; Chia-Lin Wei; Jiannis Ragoussis; Gioacchino Natoli
Journal:  Immunity       Date:  2010-03-04       Impact factor: 31.745

4.  Latent enhancers activated by stimulation in differentiated cells.

Authors:  Renato Ostuni; Viviana Piccolo; Iros Barozzi; Sara Polletti; Alberto Termanini; Silvia Bonifacio; Alessia Curina; Elena Prosperini; Serena Ghisletti; Gioacchino Natoli
Journal:  Cell       Date:  2013-01-17       Impact factor: 41.582

5.  Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages.

Authors:  Xuefen Chen; Iros Barozzi; Alberto Termanini; Elena Prosperini; Antonio Recchiuti; Jesmond Dalli; Flore Mietton; Gianluca Matteoli; Scott Hiebert; Gioacchino Natoli
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

6.  Control of inducible gene expression by signal-dependent transcriptional elongation.

Authors:  Diana C Hargreaves; Tiffany Horng; Ruslan Medzhitov
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

Review 7.  Modification of enhancer chromatin: what, how, and why?

Authors:  Eliezer Calo; Joanna Wysocka
Journal:  Mol Cell       Date:  2013-03-07       Impact factor: 17.970

8.  Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4.

Authors:  Christian R H Raetz; Teresa A Garrett; C Michael Reynolds; Walter A Shaw; Jeff D Moore; Dale C Smith; Anthony A Ribeiro; Robert C Murphy; Richard J Ulevitch; Colleen Fearns; Donna Reichart; Christopher K Glass; Chris Benner; Shankar Subramaniam; Richard Harkewicz; Rebecca C Bowers-Gentry; Matthew W Buczynski; Jennifer A Cooper; Raymond A Deems; Edward A Dennis
Journal:  J Lipid Res       Date:  2006-02-14       Impact factor: 5.922

9.  Jmjd3 contributes to the control of gene expression in LPS-activated macrophages.

Authors:  Francesca De Santa; Vipin Narang; Zhei Hwee Yap; Betsabeh Khoramian Tusi; Thomas Burgold; Liv Austenaa; Gabriele Bucci; Marieta Caganova; Samuele Notarbartolo; Stefano Casola; Giuseppe Testa; Wing-Kin Sung; Chia-Lin Wei; Gioacchino Natoli
Journal:  EMBO J       Date:  2009-09-24       Impact factor: 11.598

10.  A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response.

Authors:  Laurens Kruidenier; Chun-wa Chung; Zhongjun Cheng; John Liddle; KaHing Che; Gerard Joberty; Marcus Bantscheff; Chas Bountra; Angela Bridges; Hawa Diallo; Dirk Eberhard; Sue Hutchinson; Emma Jones; Roy Katso; Melanie Leveridge; Palwinder K Mander; Julie Mosley; Cesar Ramirez-Molina; Paul Rowland; Christopher J Schofield; Robert J Sheppard; Julia E Smith; Catherine Swales; Robert Tanner; Pamela Thomas; Anthony Tumber; Gerard Drewes; Udo Oppermann; Dinshaw J Patel; Kevin Lee; David M Wilson
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962

View more
  12 in total

Review 1.  Systems-level analysis of innate immunity.

Authors:  Daniel E Zak; Vincent C Tam; Alan Aderem
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

Review 2.  Antiviral innate immunity through the lens of systems biology.

Authors:  Shashank Tripathi; Adolfo Garcia-Sastre
Journal:  Virus Res       Date:  2015-12-03       Impact factor: 3.303

Review 3.  Histone demethylase Jumonji D3 (JMJD3/KDM6B) at the nexus of epigenetic regulation of inflammation and the aging process.

Authors:  Antero Salminen; Kai Kaarniranta; Mikko Hiltunen; Anu Kauppinen
Journal:  J Mol Med (Berl)       Date:  2014-06-14       Impact factor: 4.599

4.  Circulating Inflammatory-Associated Proteins in the First Month of Life and Cognitive Impairment at Age 10 Years in Children Born Extremely Preterm.

Authors:  Karl C K Kuban; Robert M Joseph; Thomas M O'Shea; Timothy Heeren; Raina N Fichorova; Laurie Douglass; Hernan Jara; Jean A Frazier; Deborah Hirtz; Julie Vanier Rollins; Nigel Paneth
Journal:  J Pediatr       Date:  2016-10-24       Impact factor: 4.406

5.  Divergent signalling pathways regulate lipopolysaccharide-induced eRNA expression in human monocytic THP1 cells.

Authors:  James A Heward; Benoit T Roux; Mark A Lindsay
Journal:  FEBS Lett       Date:  2014-12-29       Impact factor: 4.124

6.  NET23/STING promotes chromatin compaction from the nuclear envelope.

Authors:  Poonam Malik; Nikolaj Zuleger; Jose I de las Heras; Natalia Saiz-Ros; Alexandr A Makarov; Vassiliki Lazou; Peter Meinke; Martin Waterfall; David A Kelly; Eric C Schirmer
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

7.  The transcriptional repressor Hes1 attenuates inflammation by regulating transcription elongation.

Authors:  Yingli Shang; Maddalena Coppo; Teng He; Fei Ning; Li Yu; Lan Kang; Bin Zhang; Chanyang Ju; Yu Qiao; Baohong Zhao; Manfred Gessler; Inez Rogatsky; Xiaoyu Hu
Journal:  Nat Immunol       Date:  2016-06-20       Impact factor: 25.606

8.  Epigenetic Landscape during Coronavirus Infection.

Authors:  Alexandra Schäfer; Ralph S Baric
Journal:  Pathogens       Date:  2017-02-15

Review 9.  Epigenetic Control of Macrophage Polarisation and Soluble Mediator Gene Expression during Inflammation.

Authors:  Theodore S Kapellos; Asif J Iqbal
Journal:  Mediators Inflamm       Date:  2016-04-10       Impact factor: 4.711

10.  Regulation of Epigenetic Modifiers, Including KDM6B, by Interferon-γ and Interleukin-4 in Human Macrophages.

Authors:  Gökçe Yıldırım-Buharalıoğlu; Mark Bond; Graciela B Sala-Newby; Charles C T Hindmarch; Andrew C Newby
Journal:  Front Immunol       Date:  2017-02-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.